Cycurion, Inc. — Form 8-K
Filed July 16, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 78/100
What the filing says
On July 10, 2026, Nasdaq notified Cycurion (NASDAQ: CYCU) that its stock failed the $1.00 minimum bid price requirement for 31 consecutive business days (May 26–July 9, 2026) and determined the company ineligible for the standard 180-day cure period because it executed a 1-for-30 reverse split on October 27, 2025. Trading suspension was scheduled for July 21, 2026, but the company timely requested a hearing before the Nasdaq Hearings Panel (due July 17) to stay suspension pending appeal. The company claims annual revenue exceeding $28M and states operations remain unaffected.
Why this rating
Delisting threat is existential risk for a $10.1M market-cap company—loss of Nasdaq listing would severely impair liquidity and valuation. Stock collapse already occurred (sub-$1.00 price). However, appeal is ongoing and trading continues; outcome uncertain.
See more from July 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.